SCHEMBL1014760

SCHEMBL1014760

O=C(COCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1cccc(-n2cccc2)c1.[NaH]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 7/20 0.54
POLB P06746 1/20 0.50
G6PD P11413 1/20 0.50
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 2/20 0.42
AKR1C4 P17516 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
TRPM4 Q8TD43 2/20 0.41
TP53 P04637 1/20 0.41
GRIK1 P39086 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016386 0.99 SERPINE1 (0.55) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1014763 0.98 SERPINE1 (0.54) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1015514 0.89 SERPINE1 (0.44) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1014762 0.89 SERPINE1 (0.44) SERPINE1POLBG6PDGAAMEN1
SCHEMBL1797569 0.80 SERPINE1 (0.56) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL22468222 0.79 SERPINE1 (0.75) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1015946 0.79 SERPINE1 (0.54) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1016298 0.79 SERPINE1 (0.54) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL29492572 0.78 SERPINE1 (0.77) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1016107 0.78 SERPINE1 (0.77) SERPINE1POLBG6PDKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990057-B1 PAI-1 INHIBITOR FOR USE IN ENHANCING THE ANTITUMOR EFFECT OF AN ANTITUMOR AGENT IN A PATIENT RENASCIENCE CO LTD (JP) 2019-03-20 EP disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 EP disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed